Circulating Tumor DNA

Clinical trial NCT06923527 · RECRUITING

Trial details

NCT number: NCT06923527
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ER+ Breast Cancer

Start date: 2025-09-30
Primary completion: 2027-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.